Close Window

Digital Look Email A Friend

Oxford Biomedica CEO John Dawson to step down

Published by Frank Prenesti on 17th January 2022

(Sharecast News) - Oxford Biomedica chief executive John Dawson said he was stepping down after 13 years at the helm of the Gene and cell therapy firm which helped develop a Covid-19 vaccine with AstraZeneca.

URL: http://www.digitallook.com/dl/news/story/32395137/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.